fbpx Skip to main content

Member's Profile

Poseida Therapeutics, Inc.

9390 Towne Centre Dr Ste 200
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2015
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Poseida Therapeutics, Inc.
Biotech Company
Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseidas lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma. Poseida has assembled a suite of industry-leading gene engineering technologies, including the piggyBac DNA Modification System, TAL-CLOVER and Cas-CLOVER site-specific nucleases, and Footprint-Free Gene Editing (FFGE).
Related News
No related news posted by this Member